Dr Mohan's Diabetes Specialities Centre, WHO Collaborating Centre for Non Communicable Diseases Prevention and Control, Madras Diabetes Research Foundation, ICMR Centre for Advanced Research on Diabetes, Chennai, India.
Regional Medical Research Centre, Dibrugarh, India.
Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596. doi: 10.1016/S2213-8587(17)30174-2. Epub 2017 Jun 7.
Previous studies have not adequately captured the heterogeneous nature of the diabetes epidemic in India. The aim of the ongoing national Indian Council of Medical Research-INdia DIABetes study is to estimate the national prevalence of diabetes and prediabetes in India by estimating the prevalence by state.
We used a stratified multistage design to obtain a community-based sample of 57 117 individuals aged 20 years or older. The sample population represented 14 of India's 28 states (eight from the mainland and six from the northeast of the country) and one union territory. States were sampled in a phased manner: phase I included Tamil Nadu, Chandigarh, Jharkhand, and Maharashtra, sampled between Nov 17, 2008, and April 16, 2010; phase II included Andhra Pradesh, Bihar, Gujarat, Karnataka, and Punjab, sampled between Sept 24, 2012, and July 26, 2013; and the northeastern phase included Assam, Mizoram, Arunachal Pradesh, Tripura, Manipur, and Meghalaya, with sampling done between Jan 5, 2012, and July 3, 2015. Capillary oral glucose tolerance tests were used to diagnose diabetes and prediabetes in accordance with WHO criteria. Our methods did not allow us to differentiate between type 1 and type 2 diabetes. The prevalence of diabetes in different states was assessed in relation to socioeconomic status (SES) of individuals and the per-capita gross domestic product (GDP) of each state. We used multiple logistic regression analysis to examine the association of various factors with the prevalence of diabetes and prediabetes.
The overall prevalence of diabetes in all 15 states of India was 7·3% (95% CI 7·0-7·5). The prevalence of diabetes varied from 4·3% in Bihar (95% CI 3·7-5·0) to 10·0% (8·7-11·2) in Punjab and was higher in urban areas (11·2%, 10·6-11·8) than in rural areas (5·2%, 4·9-5·4; p<0·0001) and higher in mainland states (8·3%, 7·9-8·7) than in the northeast (5·9%, 5·5-6·2; p<0·0001). Overall, 1862 (47·3%) of 3938 individuals identified as having diabetes had not been diagnosed previously. States with higher per-capita GDP seemed to have a higher prevalence of diabetes (eg, Chandigarh, which had the highest GDP of US$ 3433, had the highest prevalence of 13·6%, 12.8-15·2). In rural areas of all states, diabetes was more prevalent in individuals of higher SES. However, in urban areas of some of the more affluent states (Chandigarh, Maharashtra, and Tamil Nadu), diabetes prevalence was higher in people with lower SES. The overall prevalence of prediabetes in all 15 states was 10·3% (10·0-10·6). The prevalence of prediabetes varied from 6·0% (5·1-6·8) in Mizoram to 14·7% (13·6-15·9) in Tripura, and the prevalence of impaired fasting glucose was generally higher than the prevalence of impaired glucose tolerance. Age, male sex, obesity, hypertension, and family history of diabetes were independent risk factors for diabetes in both urban and rural areas.
There are large differences in diabetes prevalence between states in India. Our results show evidence of an epidemiological transition, with a higher prevalence of diabetes in low SES groups in the urban areas of the more economically developed states. The spread of diabetes to economically disadvantaged sections of society is a matter of great concern, warranting urgent preventive measures.
Indian Council of Medical Research and Department of Health Research, Ministry of Health and Family Welfare, Government of India.
之前的研究没有充分捕捉到印度糖尿病流行的异质性。正在进行的印度医学研究理事会-印度糖尿病研究的目的是通过估计各州的患病率来估计印度的全国糖尿病和前期糖尿病患病率。
我们使用分层多阶段设计,从印度 28 个邦中的 14 个(大陆的 8 个和东北部的 6 个)和一个联邦属地获得基于社区的 57117 名 20 岁或以上的个体样本。抽样人群代表了印度 14 个邦中的 14 个(大陆的 8 个和东北部的 6 个)和一个联邦属地,其中 8 个邦包括泰米尔纳德邦、昌迪加尔、恰蒂斯加尔邦和马哈拉施特拉邦,抽样时间为 2008 年 11 月 17 日至 2010 年 4 月 16 日;第二个阶段包括安得拉邦、比哈尔邦、古吉拉特邦、卡纳塔克邦和旁遮普邦,抽样时间为 2012 年 9 月 24 日至 2013 年 7 月 26 日;东北部阶段包括阿萨姆邦、米佐拉姆邦、阿鲁纳恰尔邦、特里普拉邦、曼尼普尔邦和梅加拉亚邦,抽样时间为 2012 年 1 月 5 日至 2015 年 7 月 3 日。根据世界卫生组织的标准,使用毛细血管口服葡萄糖耐量试验来诊断糖尿病和前期糖尿病。我们的方法不允许我们区分 1 型和 2 型糖尿病。不同州的糖尿病患病率与个人的社会经济地位(SES)和每个州的人均国内生产总值(GDP)有关。我们使用多元逻辑回归分析来研究各种因素与糖尿病和前期糖尿病患病率的关联。
印度所有 15 个邦的总体糖尿病患病率为 7.3%(95%CI 7.0-7.5)。糖尿病的患病率从比哈尔邦的 4.3%(95%CI 3.7-5.0)到旁遮普邦的 10.0%(8.7-11.2)不等,城市地区(11.2%,10.6-11.8)高于农村地区(5.2%,4.9-5.4;p<0.0001),大陆邦(8.3%,7.9-8.7)高于东北部邦(5.9%,5.5-6.2;p<0.0001)。总的来说,在 3938 名被诊断为患有糖尿病的人中,有 1862 名(47.3%)之前未被诊断过。人均 GDP较高的州似乎有更高的糖尿病患病率(例如,人均 GDP最高的昌迪加尔为 3433 美元,其患病率最高,为 13.6%,12.8-15.2%)。在所有州的农村地区,SES 较高的个体中糖尿病更为普遍。然而,在一些较富裕的邦的城市地区(昌迪加尔、马哈拉施特拉邦和泰米尔纳德邦),SES 较低的人群中糖尿病患病率更高。所有 15 个邦的前期糖尿病总患病率为 10.3%(10.0-10.6)。前期糖尿病的患病率从米佐拉姆邦的 6.0%(5.1-6.8)到特里普拉邦的 14.7%(13.6-15.9)不等,空腹血糖受损的患病率普遍高于葡萄糖耐量受损的患病率。年龄、男性、肥胖、高血压和糖尿病家族史是城乡地区糖尿病的独立危险因素。
印度各州的糖尿病患病率存在很大差异。我们的研究结果表明存在流行病学转变的证据,在经济发达的州的城市地区,社会经济地位较低的群体中,糖尿病的患病率更高。糖尿病向社会经济弱势群体的传播令人深感担忧,需要采取紧急预防措施。
印度医学研究理事会和印度卫生与家庭福利部下属的卫生研究部,印度政府。